Sunday, November 1, 2026

Expert Calls for Abandoning Regime-Change Expectations in Dealing with Pyongyang

The article suggests a paradigm shift in North Korea policy, emphasizing long-term coexistence over outdated hopes for regime change.

Revolutionary AI Korean Language Tutor: How ETRI’s Tech Outscores GPT Models in 2026

ETRI developed an AI Korean language education technology enabling foreign learners to converse freely without missing the curriculum.

Galaxy Z Fold 7 Is Here — And It’s Thinner, Smarter, and More Mainstream

Samsung unveils Galaxy Z Fold 7 and Z Flip 7 at Galaxy Unpacked 2025, showcasing innovation in foldable smartphones.

News1

CG Bio Treats First U.S. Patient With Bone Graft Substitute, Advances FDA Approval

Sigibio accelerates clinical development for FDA approval after the first U.S. patient procedure with its next-gen bone substitute, Novosis Putty.

LG CNS Reports 4.2% Revenue Growth in AI Sector: What This Means for Investors

LG CNS continues to grow in revenue thanks to AI, but profitability has decreased due to expanded investments in the sector.

Is Winuf IV the Future of Nutritional IV Therapy? A Deep Dive into Omega-3’s Role in Healing

JW Pharmaceutical introduces clinical applications of omega-3 based nutrient infusion Winuf Inj. to medical professionals.

Next-Gen Surface Induction Radiation Therapy: A Game Changer for Breast Cancer Patients?

Breast cancer patients may soon avoid discomfort from tattoos or markings during radiation therapy.

L&K Biomed’s Pectus Implant: A Game-Changer in Minimally Invasive Surgery at Mayo Clinic

L&K Biomed successfully performed surgery using their chest wall implant at Mayo Clinic, boosting their North American market entry.

LG Unveils K-EXAONE 2.0: The 750B Parameter AI Model Set to Transform Global Markets

LG's AI Research Institute unveils the K-EXAONE 2.0, a massive AI model, accelerating its strategy in the global AI market.

Why Hanmi Pharmaceutical’s Pyeongtaek Manufacturing Center Achieved Top Safety Rating Again in 2026?

Hanmi Pharmaceutical's Pyeongtaek manufacturing center received the highest P grade in a safety management assessment by the Ministry of Employment and Labor.

IKS04: The New ADC Candidate for GI Cancer Approved by FDA – What You Need to Know

LigaChemBio's ADC platform technology enters U.S. clinical trials for gastrointestinal cancer, showcasing its competitive edge in the field.

Unlock the Secret to Fat Loss: How MJ2 Probiotics and HN001 Postbiotics Can Transform Your Body

Huons has confirmed the fat-reducing effects of its probiotics and postbiotics in human trials and is seeking health supplement approval.

Samsung SDI’s Solid-State Battery: Will Humanoid Robots Lead the Charge by 2027?

Samsung SDI reveals that its first commercialization project for solid-state batteries is likely to be for humanoid applications.

Osstem Implant Secures CE Certification for T2 Plus, T2, and N1 Dental X-Ray Devices: What This Means for the EU Market

Osstem Implant has received CE certification for key dental X-ray products under EU medical device regulations (MDR).

Revolutionary AI Breakthrough: How KAIST’s New Tech Reduces Sensory Confusion in Multimodal AI

A key technology has been developed to end the era of AI claiming to hear what it cannot and see what is not there.

Samsung SDS Q2 Revenue Rises 5.9% YoY to $2.48 Billion

Samsung SDS reports Q2 2026 revenue of $2.48 billion, a 5.9% increase, with operating profit rising 0.7% to $155 million.

Samsung Electronics Invests $12.1 Billion in Q2 to Meet Long-Term AI Demand

Samsung Electronics invested $12.1 billion in Q2 2026, focusing on AI-driven demand and expanding manufacturing capacity across sectors.

Top News

- Our Sponsors Ad -

Follow us